Skip to content

Cheetah - Sterile Glove and Clean Instrument Change at the Time of Wound Closure to Reduce Surgical Site Infection

Cheetah - a Cluster Randomized Trial of Sterile Glove and Clean Instrument Change at the Time of Wound Closure to Reduce Surgical Site Infection (SSI). A Trial in Low and Middle Income Countries (LMICs) and A Trial in High Income Countries (HICs)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03980652
Acronym
Cheetah
Enrollment
12800
Registered
2019-06-10
Start date
2020-05-31
Completion date
2021-12-31
Last updated
2020-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infection

Brief summary

To assess whether the practice of using separate sterile gloves and instruments to close wounds at the end of surgery compared to current routine hospital practice can reduce surgical site infection

Detailed description

Internal Pilot The aim of the 12-month internal pilot is to assess: 1. whether hospitals adhere to their allocation 2. what proportion of patients who are eligible for ChEETAh can be followed up successfully at 30 days after their surgery Main Study To assess whether the practice of using separate sterile gloves and instruments to close wounds at the end of surgery compared to current routine hospital practice can reduce surgical site infection at 30-days post-surgery for patients undergoing clean-contaminated, contaminated or dirty abdominal surgery

Interventions

PROCEDUREChange of gloves and sterile instruments

Change of gloves and use of separate , sterile instruments before closing the abdominal wall

Sponsors

University of Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

The Randomisation is at the hospital level and hospitals will be randomised to the intervention (of separating sterile surgical instruments and gloves at the time of wound closure). Patients will not be made aware of the hospital/theatre randomisation, as patients would also not be aware of the specifics of any operation

Intervention model description

Cluster randomised controlled trial

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Countries: LMICs defined by the Development Assistance Committee (DAC) Official Development Assistance (ODA) list where there are at least 4 eligible hospitals per country in HIC-CHEETAH protocol (HICs are those that do not appear on the Organisation for Economic Co-operation and Development's Official Development Assistance (ODA) list * Hospitals (clusters): in LMICs where glove and instrument change is not currently routine hospital practice * Participants: Patients undergoing abdominal surgery who satisfy the following criteria are eligible: * Emergency (surgery on an unplanned admission) or elective (surgery on a planned admission) * Intraoperative finding of clean-contaminated, contaminated or dirty surgery * with at least one abdominal incision that is ≥5cm * Aged 16 years and over on the day of surgery (applicable to HIC-CHEETAH protocol only) Participant

Exclusion criteria

• Patients undergoing caesarean section

Design outcomes

Primary

MeasureTime frameDescription
Surgical Site Infection (SSI) at 30-days post-surgery30-days post-surgeryThe Centre for Disease Control (CDC) definition will be used in ChEETAh to identify deep incisional or superficial incisional SSIs

Secondary

MeasureTime frameDescription
SSI before discharge from hospitalup to 30 daysSSI will be assessed following the index operation, at the point of discharge, and assessed according to the Centre for Disease Control (CDC) criteria
Re-admissionwithin 30-days post-surgeryUnexpected re-admission into hospital for a wound-related problem within 30-days post surgery
Length of hospital stayLength of hospital stay for the index operation and assessed at the point of discharge up to 30 daysLength of hospital stay following surgery
Return to normal activities e.g (work, school, or family duties)The assessment will be made up to 30-days from the index operation.Return to normal activities from the date of the index operation will be assessed by a questionnaire via telephone and analysed by the Centre for Disease Control (CDC) criteria.
Deathwithin 30 days post-surgerywithin 30 days of surgery

Contacts

Primary ContactDonna Smith
cheetah@trials.bham.ac.uk+44(0)121 415 9103

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026